BOBBIE BROWN CORRECTIVE SPOT TREATMENT BROAD SPECTRUM

Manufacturer: Bobbi Brown Professional Cosmetics Inc. | ELGC K.K. | Estee Lauder Pennsylvania Distribution Center 2 (PADC 2) | Estee Lauder Inc. | ESTEE LAUDER COSMETICS DISTRIBUTION CENTER | ESTEE LAUDER COSMETICS, LTD | ESTEE LAUDER COSMETICS, LTD. | ESTEE LAUDER N.V. | LEN-RON MANUFACTURING DIVISION OF ARAMIS INC | NORTEC KEYSTONE | NORTHTEC BRISTOL | NORTHTEC KEYSTONE | WHITMAN LABORATORIES, LTD. | Aveda Corporation | Pennsylvania Logistics Center | NIPPON SHIKAZAI
Effective date: 2012-10-04
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:33:23

Label at a glance#

ProductBOBBIE BROWN CORRECTIVE SPOT TREATMENT BROAD SPECTRUM SPF 25

Active ingredientOCTINOXATE, TITANIUM DIOXIDE

Label structure9 sections

Dosage and administration

For sunscreen use: apply liberally 15 minutes before sun exposure reapply at least every two hours use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in...

Storage and handling

Protect the product in this container from excessive heat and direct sun.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Octinoxate 7.00%
Titanium Dioxide 1.10%

Purpose

OTC - PURPOSE SECTION

Sunscreen

Use

INDICATIONS & USAGE SECTION

Helps prevent sunburn

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

Do not use on damaged or broken skin

OTC - WHEN USING SECTION

When using this product keep out of eyes. Rinse with water to remove.

OTC - STOP USE SECTION

Stop use and ask a doctor if rash occurs

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For sunscreen use:

apply liberally 15 minutes before sun exposure
reapply at least every two hours
use a water resistant sunscreen if swimming or sweating
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m.-2 p.m.
- wear long-sleeved shirts, pants, hats and sunglasses
children under 6 months of age: ask a doctor

Inactive ingredients

INACTIVE INGREDIENT SECTION

isododecane • talc • trimethylsiloxysilicate • polyethylene • alumina • diphenylsiloxy phenyl trimethicone • disteardimonium hectorite • microcrystalline wax\cera microcristallina\cire microcristalline • ascorbyl glucoside • morus nigra (mulberry) root extract • hydrolyzed rice bran extract • scutellaria baicalensis root extract • vitis vinifera (grape) fruit extract • gentiana lutea (gentian) root extract • cholesterol • stearyl glycyrrhetinate • sucrose • dimethicone • propylene carbonate • sorbitan sesquiisostearate • linoleic acid • butylene glycol • aluminum hydroxide • methicone • tocopherol • water\aqua\eau • phenoxyethanol • [+/- mica • iron oxides (ci 77492) • iron oxides (ci 77491) • iron oxides (ci 77499) • titanium dioxide (ci 77891)] <iln39231>

Other information

STORAGE AND HANDLING SECTION

Protect the product in this container from excessive heat and direct sun.

SPL UNCLASSIFIED SECTION

Dist. Bobbi Brown Professional Cosmetics
New York, N.Y. 10022

PRINCIPAL DISPLAY PANEL - 4.5 ML Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BOBBI BROWN

CORRECTIVE SPOT TREATMENT
BROAD SPECTRUM SPF 25

4.5 ML / .15 FL. OZ.

Principal Display Panel - 4.5 ML Tube Carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
64141-113-01	2019-11-27	C162847	48780-1	9855d018-eaa7-cd31-e053-dbdaa90ab51a	CORRECTIVE SPOT TREATMENT BROAD SPECTRUM SPF 25

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
64141-113-01	BOBBIE BROWN CORRECTIVE SPOT TREATMENT BROAD SPECTRUM SPF 25	1 in 1 CARTON	CREAM	1		1
64141-113-01	BOBBIE BROWN CORRECTIVE SPOT TREATMENT BROAD SPECTRUM SPF 25	4.5 mL in 1 TUBE	CREAM	4.5		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
64141-113	BOBBIE BROWN CORRECTIVE SPOT TREATMENT BROAD SPECTRUM SPF 25 (OCTINOXATE AND TITANIUM DIOXIDE) CREAM [BOBBI BROWN PROFESSIONAL COSMETICS INC.]	1	Legacy NDC, 2 package rows	20121026_8ded9f89-3106-41dd-9016-0325d6300f92.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	1
TITANIUM DIOXIDE	ACTIVE INGREDIENT	15FIX9V2JP	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	1
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	1
aluminum hydroxide	INACTIVE INGREDIENT	5QB0T2IUN0	1
aluminum oxide	INACTIVE INGREDIENT	LMI26O6933	1
ascorbyl glucoside	INACTIVE INGREDIENT	2V52R0NHXW	1
butylene glycol	INACTIVE INGREDIENT	3XUS85K0RA	1
cholesterol	INACTIVE INGREDIENT	97C5T2UQ7J	1
dimethicone	INACTIVE INGREDIENT	92RU3N3Y1O	1
diphenylsiloxy phenyl trimethicone	INACTIVE INGREDIENT	I445L28B12	1
ferric oxide red	INACTIVE INGREDIENT	1K09F3G675	1
ferric oxide yellow	INACTIVE INGREDIENT	EX438O2MRT	1
ferrosoferric oxide	INACTIVE INGREDIENT	XM0M87F357	1
gentiana lutea root	INACTIVE INGREDIENT	S72O3284MS	1
high density polyethylene	INACTIVE INGREDIENT	UG00KM4WR7	1
isododecane	INACTIVE INGREDIENT	A8289P68Y2	1
linoleic acid	INACTIVE INGREDIENT	9KJL21T0QJ	1
mica	INACTIVE INGREDIENT	V8A1AW0880	1
microcrystalline wax	INACTIVE INGREDIENT	XOF597Q3KY	1
morus nigra root	INACTIVE INGREDIENT	033456LFG1	1
phenoxyethanol	INACTIVE INGREDIENT	HIE492ZZ3T	1
propylene carbonate	INACTIVE INGREDIENT	8D08K3S51E	1
scutellaria baicalensis root	INACTIVE INGREDIENT	7J95K7ID2S	1
stearyl glycyrrhetinate	INACTIVE INGREDIENT	3YYE6VJS0P	1
sucrose	INACTIVE INGREDIENT	C151H8M554	1
talc	INACTIVE INGREDIENT	7SEV7J4R1U	1
tocopherol	INACTIVE INGREDIENT	R0ZB2556P8	1
water	INACTIVE INGREDIENT	059QF0KO0R	1
wine grape	INACTIVE INGREDIENT	3GOV20705G	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 30 matching rows.

BOBBIE BROWN CORRECTIVE SPOT TREATMENT BROAD SPECTRUM SPF 25
OCTINOXATE and TITANIUM DIOXIDE
OCTINOXATE
TITANIUM DIOXIDE
isododecane
talc
high density polyethylene
aluminum oxide
diphenylsiloxy phenyl trimethicone
microcrystalline wax
ascorbyl glucoside
morus nigra root
scutellaria baicalensis root
wine grape
gentiana lutea root
cholesterol
stearyl glycyrrhetinate
sucrose
dimethicone
propylene carbonate
linoleic acid
butylene glycol
aluminum hydroxide
tocopherol
water
phenoxyethanol
mica
ferric oxide yellow
ferric oxide red
ferrosoferric oxide

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
64141-113	64141-113-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 28 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
OCTINOXATE	4Y5P7MUD51	ACTIB
TITANIUM DIOXIDE	15FIX9V2JP	ACTIB
isododecane	A8289P68Y2	IACT
talc	7SEV7J4R1U	IACT
high density polyethylene	UG00KM4WR7	IACT
aluminum oxide	LMI26O6933	IACT
diphenylsiloxy phenyl trimethicone	I445L28B12	IACT
microcrystalline wax	XOF597Q3KY	IACT
ascorbyl glucoside	2V52R0NHXW	IACT
morus nigra root	033456LFG1	IACT
scutellaria baicalensis root	7J95K7ID2S	IACT
wine grape	3GOV20705G	IACT
gentiana lutea root	S72O3284MS	IACT
cholesterol	97C5T2UQ7J	IACT
stearyl glycyrrhetinate	3YYE6VJS0P	IACT
sucrose	C151H8M554	IACT
dimethicone	92RU3N3Y1O	IACT
propylene carbonate	8D08K3S51E	IACT
linoleic acid	9KJL21T0QJ	IACT
butylene glycol	3XUS85K0RA	IACT
aluminum hydroxide	5QB0T2IUN0	IACT
tocopherol	R0ZB2556P8	IACT
water	059QF0KO0R	IACT
phenoxyethanol	HIE492ZZ3T	IACT
mica	V8A1AW0880	IACT
ferric oxide yellow	EX438O2MRT	IACT
ferric oxide red	1K09F3G675	IACT
ferrosoferric oxide	XM0M87F357	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 186 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
sucrose	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
high density polyethylene	HIGH DENSITY POLYETHYLENE	UG00KM4WR7	FILM, EXTENDED RELEASE / TRANSDERMAL		85 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, FILM COATED / ORAL	0.2 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	TABLET, ORALLY DISINTEGRATING / ORAL		80 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
aluminum hydroxide	ALUMINUM HYDROXIDE	5QB0T2IUN0	CAPSULE / ORAL	NA		Exact identifier — unii candidate 4 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	GRANULE, FOR SUSPENSION / ORAL		296 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, EXTENDED RELEASE / ORAL		8 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, EXTENDED RELEASE / ORAL		15 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
cholesterol	CHOLESTEROL	97C5T2UQ7J	CREAM / VAGINAL	0.3 %w/w		Exact identifier — unii candidate 10 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	GRANULE / ORAL		322 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, CHEWABLE / ORAL		14 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
high density polyethylene	HIGH DENSITY POLYETHYLENE	UG00KM4WR7	TABLET / ORAL	50 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
microcrystalline wax	MICROCRYSTALLINE WAX	XOF597Q3KY	OINTMENT / TOPICAL		3575 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
cholesterol	CHOLESTEROL	97C5T2UQ7J	INJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL		7 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	FILM / BUCCAL	0.27 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		357 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	GRANULE, FOR SUSPENSION / ORAL		11 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	CAPSULE, COATED / ORAL	0.11 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
high density polyethylene	HIGH DENSITY POLYETHYLENE	UG00KM4WR7	CAPSULE, EXTENDED RELEASE / ORAL	4.53 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
phenoxyethanol	PHENOXYETHANOL	HIE492ZZ3T	CREAM / TOPICAL		57 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
high density polyethylene	HIGH DENSITY POLYETHYLENE	UG00KM4WR7	GEL / TOPICAL	26 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	CREAM / TOPICAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	ELIXIR / ORAL	4.5 mg/5ml		Exact identifier — unii candidate 35 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	TABLET / BUCCAL	0.4 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	TABLET / RECTAL	32.4 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
cholesterol	CHOLESTEROL	97C5T2UQ7J	OINTMENT / TOPICAL	5 %w/w		Exact identifier — unii candidate 10 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	CAPSULE, COATED / ORAL		87 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
high density polyethylene	HIGH DENSITY POLYETHYLENE	UG00KM4WR7	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	CAPSULE, COATED, EXTENDED RELEASE / ORAL		20 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	SUSPENSION / ORAL		6 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	LOZENGE / ORAL		50 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
microcrystalline wax	MICROCRYSTALLINE WAX	XOF597Q3KY	CREAM / VAGINAL		23 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	SUSPENSION / ORAL		234 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		18 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
high density polyethylene	HIGH DENSITY POLYETHYLENE	UG00KM4WR7	OINTMENT / TOPICAL	94 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	GRANULE, DELAYED RELEASE / ORAL		525 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	CAPSULE, EXTENDED RELEASE / ORAL		7 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	TABLET, DELAYED RELEASE / ORAL		37 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	TABLET, FILM COATED / ORAL		3 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	CAPSULE, DELAYED RELEASE / ORAL		14 mg	Exact identifier — unii candidate 21 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
6c5c6a34-6fa2-479f-a741-feaa060a82f7			8ded9f89-3106-41dd-9016-0325d6300f92	2012-10-04	Warnings	Exact identifier spl id: 6c5c6a34-6fa2-479f-a741-feaa060a82f7 spl set id: 8ded9f89-3106-41dd-9016-0325d6300f92

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.